🔎 Trials Near Me

Gara Jalqabaatti › Obesity › Oklahoma › Oklahoma City

Qorannoo klinikaalii Obesity Oklahoma City, OK keessatti

Qorannoo 10 Obesity f Oklahoma City fi naannoo isaa (kilomeetira 30 keessatti) hirmaatuu jiru. Qorannoo banaa eenyu akka hirmaatu fi akkamitti garee qorannoo akka quunnaman ilaali.

Takkalaa qorannoo (Ingiliffa)

Qorannoo hirmaatuu barbaadduu? Fuula kana jalatti agarsiisi — $99 guyyaa 30f →

A Research Study on How Well Cagrilintide and CagriSema Work in Children and Adolescents With Excess Body Weight

Namoota walitti qabaa jiraSadarkaa 3
  • Children's Physicians OU, Oklahoma City
Umuriin 8 hanga 18 · Saalaa hunda · Haaromfame 30-Ful-2026 · NCT07253285

Study to Assess the Effect and Safety of ALV-100 on Maintenance of Weight Loss

Namoota walitti qabaa jiraSadarkaa 2
  • Lynn Health Science Institute, Oklahoma City
Umuriin 18 hanga 75 · Saalaa hunda · Haaromfame 28-Ful-2026 · NCT07837973

A Platform Trial for Pediatric Participants With Obesity or Overweight (LY900040)

Namoota walitti qabaa jiraSadarkaa 3
  • University of Oklahoma Health Sciences Center, Oklahoma City
Umuriin 6 hanga 17 · Saalaa hunda · Haaromfame 24-Ful-2026 · NCT06672549

A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 Diabetes

Namoota walitti qabaa jiraSadarkaa 3
  • AURORA-2 Clinical Site, Oklahoma City
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 16-Ful-2026 · NCT07743450

Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity

Namoota walitti qabaa jiraSadarkaa 3
  • South Oklahoma Heart Research, Oklahoma City
Umuriin 18 hanga 99 · Saalaa hunda · Haaromfame 16-Ful-2026 · NCT07037459

A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight and Type 2 Diabetes

Namoota walitti qabaa jiraSadarkaa 3
  • Lynn Health Science Institute, Oklahoma City
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 14-Ful-2026 · NCT07351058

A Study of Aleniglipron in Adults With Obesity or Overweight and Type 2 Diabetes Mellitus (ACCOMPLISH-2)

Namoota walitti qabaa jiraSadarkaa 3Hojjettoota fayyaa simatamoo
  • ACCOMPLISH-2 Research Site, Yukon · Miili 14 fagaatti
Umuriin 18 hanga 79 · Saalaa hunda · Haaromfame 11-Ful-2026 · NCT07654374

Efficacy, Safety and Tolerability of Switching From Glucagon-like Peptide-1 Receptor Agonists (GLP-1RA) to Maridebart Cafraglutide in Adults With Obesity or Overweight (MARITIME-SWITCH)

Namoota walitti qabaa jiraSadarkaa 3
  • Lynn Health Science Institute, Oklahoma City
Umuriin 18 hanga 99 · Saalaa hunda · Haaromfame 27-Hag-2026 · NCT07575399

A Study to See How Safe and Effective Alirocumab is When Given Weekly to Adult Participants Who Have Hypercholesterolemia

Namoota walitti qabaa jiraSadarkaa 2
  • Lynn Health Science Institute, Oklahoma City
Umuriin 18 hanga 80 · Saalaa hunda · Haaromfame 22-Ado-2026 · NCT07477704

Uterine Preservation Via Lifestyle Transformation

Namoota walitti qabaa jiraSadarkaa 2
  • University of Oklahoma, Oklahoma City
Umuriin 18 fi ol · Dubartoota · Haaromfame 20-Ama-2026 · NCT05903131

Qorannoo Obesity magaalota biroo keessatti

Qorannoo biroo Oklahoma City keessatti

Kanneen ClinicalTrials.gov irraa argaman, daataa 06-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.